SlideShare a Scribd company logo
2
Most read
3
Most read
9
Most read
COMPLAINTS AND RECALLS 
Present By : Kandarp N. Trivedi 
M.Pharm.[PMRA]
CONTENTS : 
 Objectives 
 Complaint Handling Principle 
 Complaint Procedures 
 Classification of Defects 
 Critical Defects 
 Major Defects 
 Other Defects 
 Records of complaint Investigation 
 Recall definition 
 Recall process
OBJECTIVES : 
 To recognize the key issues in product 
complaint and recall handling 
 To identify with the specific requirements 
for organization, procedures and 
resources 
 To appreciate and develop actions to 
resolve current issues applicable to you
COMPLAINTS PRINCIPLE : 
 All complaints and other information concerning potentially 
defective products must be carefully reviewed according to written 
procedures and corrective action should be taken 
 Principle should follow bellowing criteria 
 Manage optimistically and ingeniously reviewed. 
 Handle by expert staff member. 
 Methodical investigation of the cause is necessary. 
 A foremost resource of information and knowledge. 
 Compulsory actions taken if recall decision
COMPLAINTS PROCEDURE – I : 
 Selected in charge person should have perform 
following task 
 To handle complaint 
 Decide on quantify to be taken 
 If not authorized person must advise authorized person 
of results 
 Adequate support staff 
 Access to records 
 Written procedure (SOP): 
 Describes action to be taken 
 Includes require to consider a recall
COMPLAINTS PROCEDURE – II : 
 Comprehensive investigation: 
 With individual concentration to set up whether 
"counterfeiting" may have been the cause 
 Cary out Fully recorded investigation – be a sign of all 
the details 
 QC concerned 
 Caused by product defect (discovered or suspected): 
 Regard as inspection other batches 
 Batches containing reprocessed product
COMPLAINTS PROCEDURE – III : 
 Investigation and evaluation should outcome in proper 
follow-up actions 
 possibly will take account of a "recall" 
 All decisions and manner taken should be recorded 
 Referenced in batch records 
 Records reviewed - trends and frequent problems
ADDITIONAL ACTION TO BE : 
 Inform competent authorities in case of serious 
quality problems such as: 
 defective manufacture 
 Product deterioration 
 counterfeit
CLASSIFICATION OF DEFECTS : 
 One time defect has been identified or justified , 
company should be dealing with it in a suitable way, 
even recall 
 The following system has been established in some 
countries (but it is not a WHO guideline): 
A. Critical defects 
B. Major defects 
C. Other defects
A. CRITICAL DEFECTS : 
 Individuals defects which can be critical and require 
the company to take in need of attention action by all 
reasonable resources, whether in or out of company 
hours 
Examples 
 Product labelled with inaccurate name or 
incorrect strength 
 Imitation or deliberately tampered-with product 
 Microbiological contamination of a sterile 
product
B. MAJOR DEFECTS : 
 Those defects which possibly will put the patient at a 
little hazard but are not life-threatening and will require 
the batch recall or product withdrawal within a few 
days 
Examples 
 Any labelling/leaflet misinformation which 
represents a significant hazard to the patient 
 Microbial contamination of non-sterile products 
with some risk for patients 
 Disobedience to specifications
C. OTHER DEFECTS : 
 Individuals defects which present only a insignificant 
risk to the patient — batch recall or product 
withdrawal would normally be initiated within a few 
days. 
Examples 
 Readily visible inaccessible packaging/closure 
faults 
 Contamination which may cause spoilage or dirt 
and where there is least risk to the patient
REASONS FOR RECALL : 
 Patients complaint 
 Recognition of GMP failure after release 
 Consequence of an inspection 
 Result from the in progress stability testing 
 Identified counterfeiting or tampering 
 Adverse reaction reporting 
 Appeal by the national authorities
PRODUCT RECALLS: PRINCIPLE 
“There should be a system to recall from the market 
promptly and effectively, products known or suspected to 
be defective.”
DEFINITION : 
 Recall 
 Removal from the market of specified batches of 
a product , may refer to one batch or all batches 
of product
RECALL PROCEDURE - I : 
 Designated authorized responsible person 
 To accomplish and coordinate recalls 
 Decide on measure to be taken 
 Adequate support staff 
 To handle all aspects and necessity of recall
SOP FOR RECALL : 
 Established, written and authorized 
 Detailed actions to be taken 
 Regularly reviewed and updated 
 Capable of rapid operation to required level of 
distribution chain, e.g. hospital and pharmacy 
level 
 Store recalled products in a secure, segregated 
area
DISTRIBUTION RECORDS : 
 Allocation records on hand to authorized person 
and contain enough information on: 
 Regulatory permit effective recall 
 Including for clinical tests and medical samples 
 Batch numbers and quantities 
 Wholesalers 
 Direct customers 
 Export locations
PROGRESS OF RECALL : 
 Supervise and record the progress during the recall 
 Inform all competent authorities of all countries 
where the given product had been distributed 
 Final report should include reconciliation between 
delivered and recovered products 
 Record of the disposition of the product 
 Effectiveness of procedure tested and evaluated from 
time to time with reference past events.
DISCUSSION WITH EXPERT AND STAFF : 
 Collect 3 examples of complaints or recalls from 
your experience 
 Describe the actions to be taken by the company or 
authority and the implications for all interested 
parties 
 Suggest a classification of the complaint or recall into 
critical (life-threatening), major or other
POSSIBLE ISSUES WITH RECALL PROCEDURE 
 No response to justified complaints 
 Response to unjustified complaints 
 Collapse to recall 
 Failure to correct common complaints 
 No capital to investigate 
 No superior management support 
 Senior management interference
 No access to records likewise distribution 
information/batch records 
 Incapacity to contact government during 
holidays/weekends 
 Dissimilarity on harshness of defect
REFERENCES : 
 WHO Module 5, January 2006. 
 www.authorstream.com 
 www.wikipedia.com
THANKS 
‘’Serve for Healthy India”

More Related Content

PPTX
Auditing of microbiological lab
PPTX
PPT
Complaints and recalls handling
PPT
Analytical methods validation as per ich & usp
PPTX
Batch Review And Batch Release.pptx
PPTX
Complaint handling in pharmaceutical companies,product recall,retention recor...
Auditing of microbiological lab
Complaints and recalls handling
Analytical methods validation as per ich & usp
Batch Review And Batch Release.pptx
Complaint handling in pharmaceutical companies,product recall,retention recor...

What's hot (20)

PPTX
Change control oos oot
PPTX
Validation master plan
PPTX
Documentation In Pharmaceutical Industry.pptx
PPTX
Out of specification shravan
PPTX
Complaints & Recalls
PPTX
Manufacturing operations and Control
PPTX
Quality Risk Management
PPTX
Purchase specifications & Maintenance of stores For Raw materials
PPTX
Vendor qualification
PPSX
Good Warehousing Practices
PPTX
PPTX
VENDOR QUALIFICATION 1.pptx
PPTX
Qualification
PPTX
Vendor qualification
PPTX
Drug product inspection & change control
PPTX
Audits in pharma industries
PPTX
Return and recall
PPTX
CGMP guidelines
PPTX
Vendor Audit
Change control oos oot
Validation master plan
Documentation In Pharmaceutical Industry.pptx
Out of specification shravan
Complaints & Recalls
Manufacturing operations and Control
Quality Risk Management
Purchase specifications & Maintenance of stores For Raw materials
Vendor qualification
Good Warehousing Practices
VENDOR QUALIFICATION 1.pptx
Qualification
Vendor qualification
Drug product inspection & change control
Audits in pharma industries
Return and recall
CGMP guidelines
Vendor Audit
Ad

Viewers also liked (6)

DOCX
Akhyar pulsa agen
PPT
Sop On Complaint Handling
PPTX
Market complaints and product recall
PPTX
How to handle difficult situation
PPT
Complaints and recall handling
PPT
CUSTOMER SERVICE POWERPOINT
Akhyar pulsa agen
Sop On Complaint Handling
Market complaints and product recall
How to handle difficult situation
Complaints and recall handling
CUSTOMER SERVICE POWERPOINT
Ad

Similar to Complaints and recalls (20)

PPTX
COMPLAINTS on quality of pharmaceutical products
PPTX
COMPLAINTS. UNIT IV
PPTX
A Detailed Study on Pharmaceutical Drug Recall
PPT
Compl n recal 112070804013
PPTX
drugrecallfinal-200423172250.pptx
PDF
Quality Assurance Unit IV Complaints.
PPTX
complaints on pharmaceutical industry (6th sem)
PPTX
Market complaints & product recall
PPTX
RECALL.pptx
PDF
ArunIJPTR.pdf
PPTX
post oprational activities
PPTX
Post operational activities
PPTX
Unit 4 Complaints.pptx
PPTX
Complaints in Quality Management System
PPTX
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...
PDF
Handling of Customer Complaint_Dr.A.Amsavel
PPTX
Pharmaceutical product recall
PDF
complaints recalls.pdfcvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvx
PPTX
Market Complaint Investigation and Recall
PPTX
Pharmaceuticals Recall status report
COMPLAINTS on quality of pharmaceutical products
COMPLAINTS. UNIT IV
A Detailed Study on Pharmaceutical Drug Recall
Compl n recal 112070804013
drugrecallfinal-200423172250.pptx
Quality Assurance Unit IV Complaints.
complaints on pharmaceutical industry (6th sem)
Market complaints & product recall
RECALL.pptx
ArunIJPTR.pdf
post oprational activities
Post operational activities
Unit 4 Complaints.pptx
Complaints in Quality Management System
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...
Handling of Customer Complaint_Dr.A.Amsavel
Pharmaceutical product recall
complaints recalls.pdfcvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvvx
Market Complaint Investigation and Recall
Pharmaceuticals Recall status report

Recently uploaded (20)

PPTX
Pharmacology of Heart Failure /Pharmacotherapy of CHF
PDF
Basic Mud Logging Guide for educational purpose
PPTX
PPH.pptx obstetrics and gynecology in nursing
PPTX
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
PDF
Microbial disease of the cardiovascular and lymphatic systems
PPTX
school management -TNTEU- B.Ed., Semester II Unit 1.pptx
PPTX
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
PDF
Complications of Minimal Access Surgery at WLH
PPTX
Week 4 Term 3 Study Techniques revisited.pptx
PPTX
Renaissance Architecture: A Journey from Faith to Humanism
PDF
FourierSeries-QuestionsWithAnswers(Part-A).pdf
PDF
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
PDF
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
PDF
102 student loan defaulters named and shamed – Is someone you know on the list?
PDF
O7-L3 Supply Chain Operations - ICLT Program
PDF
Supply Chain Operations Speaking Notes -ICLT Program
PPTX
The Healthy Child – Unit II | Child Health Nursing I | B.Sc Nursing 5th Semester
PPTX
Pharma ospi slides which help in ospi learning
PDF
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
PPTX
Cell Structure & Organelles in detailed.
Pharmacology of Heart Failure /Pharmacotherapy of CHF
Basic Mud Logging Guide for educational purpose
PPH.pptx obstetrics and gynecology in nursing
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
Microbial disease of the cardiovascular and lymphatic systems
school management -TNTEU- B.Ed., Semester II Unit 1.pptx
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
Complications of Minimal Access Surgery at WLH
Week 4 Term 3 Study Techniques revisited.pptx
Renaissance Architecture: A Journey from Faith to Humanism
FourierSeries-QuestionsWithAnswers(Part-A).pdf
The Lost Whites of Pakistan by Jahanzaib Mughal.pdf
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
102 student loan defaulters named and shamed – Is someone you know on the list?
O7-L3 Supply Chain Operations - ICLT Program
Supply Chain Operations Speaking Notes -ICLT Program
The Healthy Child – Unit II | Child Health Nursing I | B.Sc Nursing 5th Semester
Pharma ospi slides which help in ospi learning
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
Cell Structure & Organelles in detailed.

Complaints and recalls

  • 1. COMPLAINTS AND RECALLS Present By : Kandarp N. Trivedi M.Pharm.[PMRA]
  • 2. CONTENTS :  Objectives  Complaint Handling Principle  Complaint Procedures  Classification of Defects  Critical Defects  Major Defects  Other Defects  Records of complaint Investigation  Recall definition  Recall process
  • 3. OBJECTIVES :  To recognize the key issues in product complaint and recall handling  To identify with the specific requirements for organization, procedures and resources  To appreciate and develop actions to resolve current issues applicable to you
  • 4. COMPLAINTS PRINCIPLE :  All complaints and other information concerning potentially defective products must be carefully reviewed according to written procedures and corrective action should be taken  Principle should follow bellowing criteria  Manage optimistically and ingeniously reviewed.  Handle by expert staff member.  Methodical investigation of the cause is necessary.  A foremost resource of information and knowledge.  Compulsory actions taken if recall decision
  • 5. COMPLAINTS PROCEDURE – I :  Selected in charge person should have perform following task  To handle complaint  Decide on quantify to be taken  If not authorized person must advise authorized person of results  Adequate support staff  Access to records  Written procedure (SOP):  Describes action to be taken  Includes require to consider a recall
  • 6. COMPLAINTS PROCEDURE – II :  Comprehensive investigation:  With individual concentration to set up whether "counterfeiting" may have been the cause  Cary out Fully recorded investigation – be a sign of all the details  QC concerned  Caused by product defect (discovered or suspected):  Regard as inspection other batches  Batches containing reprocessed product
  • 7. COMPLAINTS PROCEDURE – III :  Investigation and evaluation should outcome in proper follow-up actions  possibly will take account of a "recall"  All decisions and manner taken should be recorded  Referenced in batch records  Records reviewed - trends and frequent problems
  • 8. ADDITIONAL ACTION TO BE :  Inform competent authorities in case of serious quality problems such as:  defective manufacture  Product deterioration  counterfeit
  • 9. CLASSIFICATION OF DEFECTS :  One time defect has been identified or justified , company should be dealing with it in a suitable way, even recall  The following system has been established in some countries (but it is not a WHO guideline): A. Critical defects B. Major defects C. Other defects
  • 10. A. CRITICAL DEFECTS :  Individuals defects which can be critical and require the company to take in need of attention action by all reasonable resources, whether in or out of company hours Examples  Product labelled with inaccurate name or incorrect strength  Imitation or deliberately tampered-with product  Microbiological contamination of a sterile product
  • 11. B. MAJOR DEFECTS :  Those defects which possibly will put the patient at a little hazard but are not life-threatening and will require the batch recall or product withdrawal within a few days Examples  Any labelling/leaflet misinformation which represents a significant hazard to the patient  Microbial contamination of non-sterile products with some risk for patients  Disobedience to specifications
  • 12. C. OTHER DEFECTS :  Individuals defects which present only a insignificant risk to the patient — batch recall or product withdrawal would normally be initiated within a few days. Examples  Readily visible inaccessible packaging/closure faults  Contamination which may cause spoilage or dirt and where there is least risk to the patient
  • 13. REASONS FOR RECALL :  Patients complaint  Recognition of GMP failure after release  Consequence of an inspection  Result from the in progress stability testing  Identified counterfeiting or tampering  Adverse reaction reporting  Appeal by the national authorities
  • 14. PRODUCT RECALLS: PRINCIPLE “There should be a system to recall from the market promptly and effectively, products known or suspected to be defective.”
  • 15. DEFINITION :  Recall  Removal from the market of specified batches of a product , may refer to one batch or all batches of product
  • 16. RECALL PROCEDURE - I :  Designated authorized responsible person  To accomplish and coordinate recalls  Decide on measure to be taken  Adequate support staff  To handle all aspects and necessity of recall
  • 17. SOP FOR RECALL :  Established, written and authorized  Detailed actions to be taken  Regularly reviewed and updated  Capable of rapid operation to required level of distribution chain, e.g. hospital and pharmacy level  Store recalled products in a secure, segregated area
  • 18. DISTRIBUTION RECORDS :  Allocation records on hand to authorized person and contain enough information on:  Regulatory permit effective recall  Including for clinical tests and medical samples  Batch numbers and quantities  Wholesalers  Direct customers  Export locations
  • 19. PROGRESS OF RECALL :  Supervise and record the progress during the recall  Inform all competent authorities of all countries where the given product had been distributed  Final report should include reconciliation between delivered and recovered products  Record of the disposition of the product  Effectiveness of procedure tested and evaluated from time to time with reference past events.
  • 20. DISCUSSION WITH EXPERT AND STAFF :  Collect 3 examples of complaints or recalls from your experience  Describe the actions to be taken by the company or authority and the implications for all interested parties  Suggest a classification of the complaint or recall into critical (life-threatening), major or other
  • 21. POSSIBLE ISSUES WITH RECALL PROCEDURE  No response to justified complaints  Response to unjustified complaints  Collapse to recall  Failure to correct common complaints  No capital to investigate  No superior management support  Senior management interference
  • 22.  No access to records likewise distribution information/batch records  Incapacity to contact government during holidays/weekends  Dissimilarity on harshness of defect
  • 23. REFERENCES :  WHO Module 5, January 2006.  www.authorstream.com  www.wikipedia.com
  • 24. THANKS ‘’Serve for Healthy India”